Association between the atherogenic index of plasma and coronary collateral circulation in patients with chronic

Shutong Dong1, Jiaming Qiao1, Ang Gao1

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing, 100029, China.

PubMed

Insights

High atherogenic index of plasma (AIP) is linked to poor coronary collateral circulation (CCC) in coronary artery disease (CAD) patients with chronic total occlusion (CTO). AIP may improve identification of poor CCC in clinical practice.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biochemistry

Background:

  • Coronary artery disease (CAD) poses a significant health burden globally.
  • Coronary collateral circulation (CCC) plays a crucial role in mitigating ischemic damage in CAD.
  • Chronic total occlusion (CTO) presents a complex challenge in CAD management.

Purpose of the Study:

  • To investigate the association between the atherogenic index of plasma (AIP) and the formation of CCC in CAD patients with CTO.
  • To determine if AIP is an independent predictor of poor CCC in this patient cohort.

Main Methods:

  • Retrospective analysis of 1093 CAD patients with CTO undergoing coronary angiography.
  • Classification of patients into good and poor CCC groups based on the Rentrop scoring system.
  • Calculation of AIP using the formula: log (triglyceride/high-density lipoprotein cholesterol).

Main Results:

  • Patients with poor CCC exhibited significantly higher AIP compared to those with good CCC (p < 0.001).
  • Multivariate logistic regression confirmed an independent association between elevated AIP and poor CCC (p < 0.001).
  • Inclusion of AIP improved the accuracy in identifying poor CCC (AUC increased from 0.661 to 0.721).

Conclusions:

  • Elevated AIP is independently associated with an increased risk of poor CCC in CAD patients with CTO.
  • AIP demonstrates potential as a valuable biomarker for identifying patients with suboptimal collateralization.
  • These findings suggest AIP could enhance clinical risk stratification and treatment strategies for CTO patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...